1. Home
  2. TYRA vs MNRO Comparison

TYRA vs MNRO Comparison

Compare TYRA & MNRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TYRA
  • MNRO
  • Stock Information
  • Founded
  • TYRA 2018
  • MNRO 1957
  • Country
  • TYRA United States
  • MNRO United States
  • Employees
  • TYRA N/A
  • MNRO N/A
  • Industry
  • TYRA Biotechnology: Pharmaceutical Preparations
  • MNRO Automotive Aftermarket
  • Sector
  • TYRA Health Care
  • MNRO Consumer Discretionary
  • Exchange
  • TYRA Nasdaq
  • MNRO Nasdaq
  • Market Cap
  • TYRA 571.9M
  • MNRO 481.5M
  • IPO Year
  • TYRA 2021
  • MNRO 1991
  • Fundamental
  • Price
  • TYRA $11.71
  • MNRO $17.29
  • Analyst Decision
  • TYRA Strong Buy
  • MNRO Buy
  • Analyst Count
  • TYRA 7
  • MNRO 4
  • Target Price
  • TYRA $30.43
  • MNRO $20.75
  • AVG Volume (30 Days)
  • TYRA 201.1K
  • MNRO 1.1M
  • Earning Date
  • TYRA 08-14-2025
  • MNRO 07-30-2025
  • Dividend Yield
  • TYRA N/A
  • MNRO 7.13%
  • EPS Growth
  • TYRA N/A
  • MNRO N/A
  • EPS
  • TYRA N/A
  • MNRO N/A
  • Revenue
  • TYRA N/A
  • MNRO $1,203,187,000.00
  • Revenue This Year
  • TYRA N/A
  • MNRO $1.31
  • Revenue Next Year
  • TYRA N/A
  • MNRO $2.56
  • P/E Ratio
  • TYRA N/A
  • MNRO N/A
  • Revenue Growth
  • TYRA N/A
  • MNRO N/A
  • 52 Week Low
  • TYRA $6.42
  • MNRO $12.20
  • 52 Week High
  • TYRA $29.60
  • MNRO $30.18
  • Technical
  • Relative Strength Index (RSI)
  • TYRA 61.31
  • MNRO 62.49
  • Support Level
  • TYRA $9.96
  • MNRO $15.51
  • Resistance Level
  • TYRA $11.48
  • MNRO $16.12
  • Average True Range (ATR)
  • TYRA 0.73
  • MNRO 0.70
  • MACD
  • TYRA 0.06
  • MNRO 0.14
  • Stochastic Oscillator
  • TYRA 75.43
  • MNRO 98.09

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

About MNRO Monro Inc.

Monro Inc is an operator of retail tire and automotive repair stores in the United States. The company offers replacement tires and tire related services, automotive undercar repair services, and a broad range of routine maintenance services, on passenger cars, light trucks, and vans. It also provides other products and services for brakes; mufflers and exhaust systems; and steering, drive train, suspension, and wheel alignment.

Share on Social Networks: